Pnc Financial Services Group, Inc. Axsome Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,669 shares of AXSM stock, worth $576,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,669

Previous 5,339 6.18%

Holding current value

$576,480

Previous $451,000 46.56%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$80.05 - $137.75 $26,416 - $45,457	330 Added 6.18%	5,669 $661,000
Q4 2024 Feb 07, 2025	SELL	$83.08 - $100.49 $7,477 - $9,044	-90 Reduced 1.66%	5,339 $451,000
Q3 2024 Nov 08, 2024	BUY	$78.93 - $95.84 $5,209 - $6,325	66 Added 1.23%	5,429 $487,000
Q2 2024 Aug 09, 2024	SELL	$65.72 - $80.5 $1,445 - $1,771	-22 Reduced 0.41%	5,363 $431,000
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $3,538 - $4,979	51 Added 0.96%	5,385 $429,000
Q4 2023 Feb 09, 2024	SELL	$57.42 - $83.61 $976 - $1,421	-17 Reduced 0.32%	5,334 $424,000
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $12,188 - $14,468	-176 Reduced 3.18%	5,351 $373,000
Q2 2023 Aug 11, 2023	BUY	$58.41 - $90.35 $7,885 - $12,197	135 Added 2.5%	5,527 $397,000
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $6,014 - $7,725	-103 Reduced 1.87%	5,392 $332,000
Q4 2022 Feb 10, 2023	SELL	$39.94 - $79.72 $4,193 - $8,370	-105 Reduced 1.88%	5,495 $423,000
Q3 2022 Nov 10, 2022	SELL	$36.06 - $69.85 $565,673 - $1.1 Million	-15,687 Reduced 73.69%	5,600 $249,000
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $760 - $1,636	35 Added 0.16%	21,287 $815,000
Q1 2022 May 12, 2022	SELL	$23.7 - $41.39 $23 - $41	-1 Reduced -0.0%	21,252 $879,000
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $1,289 - $1,821	-42 Reduced 0.2%	21,253 $802,000
Q3 2021 Nov 05, 2021	BUY	$19.91 - $68.26 $696 - $2,389	35 Added 0.16%	21,295 $701,000
Q2 2021 Aug 06, 2021	BUY	$50.63 - $73.5 $1,620 - $2,352	32 Added 0.15%	21,260 $1.43 Million
Q1 2021 May 07, 2021	BUY	$55.91 - $81.44 $27,675 - $40,312	495 Added 2.39%	21,228 $1.2 Million
Q2 2020 Aug 07, 2020	BUY	$49.87 - $98.69 $984,084 - $1.95 Million	19,733 Added 1973.3%	20,733 $1.71 Million
Q4 2019 Feb 07, 2020	BUY	$16.71 - $106.24 $16,710 - $106,240	1,000 New	1,000 $103,000

Others Institutions Holding AXSM

# of Institutions

409

Shares Held

36.6M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.36B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Axsome Therapeutics, Inc. Transaction History